MS-STAT2: A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo in secondary progressive multiple sclerosis, in slowing the progression of disability

Project Details

StatusActive
Effective start/end date1/03/1731/08/23

Funding

  • Other: £78,785.00